Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹22.38
Market cap: ₹123.5 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 51.0×Sector 47.3×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Earnings Call 2 Business Update 2 Board Meeting Date 2 Annual General Meeting 2 Results Correction 1 Price Movement Clarification 1 Other Announcement 1 Management Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Jul 2026 11:45 IST NSE

Results Correction

Balaxi Pharmaceuticals Results Correction

Balaxi Pharmaceuticals clarified reporting discrepancies in its March 2026 financial results. The company filed revised XBRL results to correct inadvertent errors in expense and income figures.

Read the filing ↗